Comparison of immunogenical potency of Leishmania major (MRHO/IR/75/ER) antigens prepared by 3 different methods in conjunction with Alum-Naltrexone adjuvant in BALB/c miceFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 7 December 2018

References

• M.BessatA.OkpanmaE.ShanatLeishmaniasis: epidemiology, control and future perspectives with special emphasis onEgypt J Trop Dis22015
   Google Scholar
• E.HandmanLeishmaniasis: current status of vaccine developmentClin Microbiol Rev142001229243
   PubMed Web of Science ®Google Scholar
• G.MatlashewskiLeishmania infection and virulenceMed Microbiol Immunol19020013742
   Web of Science ®Google Scholar
• N.SalamW.M.Al-ShaqhaA.AzziLeishmaniasis in the Middle East: incidence and epidemiologyPLoS NeglTrop Dis82014e3208
   PubMed Web of Science ®Google Scholar
• L.KedzierskiLeishmaniasis vaccine: where are we today?J Global Infect Dis22010177
   PubMedGoogle Scholar
• H.EngersR.BergquistF.ModabberProgress on vaccines against parasitesDev Biol Stand8719957384
   Google Scholar
• M.D.SadickR.M.LocksleyH.V.RaffDevelopment of cellular immunity in cutaneous leishmaniasis due to Leishmania tropicaJ Infect Dis1501984135138
   PubMed Web of Science ®Google Scholar
• J.AguilarE.RodriguezVaccine adjuvants revisitedVaccine25200737523762
   PubMed Web of Science ®Google Scholar
• Y.SohrabiM.R.JaafariA.MohammadiS.EskandariA.KhamesipourEvaluation of immune response against leishmaniasis in resistance C57 BL/6 mice immunized with liposomes containing autoclaved Leishmania major with BCGCell Mol Biol Lett10Suppl 12005S98
   Google Scholar
• S.G.ReedS.BertholetR.N.ColerM.FriedeNew horizons in adjuvants for vaccine developmentTrends Immunol3020092332
   PubMed Web of Science ®Google Scholar
• D.M.WalkerS.OghumuG.GuptaB.S.McGwireM.E.DrewA.R.SatoskarMechanisms of cellular invasion by intracellular parasitesCell Mol Life Sci71201412451263
   PubMed Web of Science ®Google Scholar
• E.De GregorioE.TrittoR.RappuoliAlum adjuvanticity: unraveling a century old mysteryEur J Immunol38200820682071
   PubMed Web of Science ®Google Scholar
• R.K.GuptaB.E.RostE.RelyveldG.R.SiberAdjuvant properties of aluminum and calcium compounds. Vaccine design1995Springer229248
   Google Scholar
• H.T.M.VoB.C.BaudnerS.SammicheliM.IannaconeU.D’OroD.Picciolialum/Toll-like receptor 7 adjuvant enhances the expansion of Memory B cell compartment Within the Draining lymph nodeFront Immunol92018641
   Web of Science ®Google Scholar
• Z.KhorshidvandS.ShahabiH.MohamadzadeA.DaryaniK.H.TappehMixture of alum–naloxone and alum–naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB/c miceExp Parasitol16220162834
   Web of Science ®Google Scholar
• P.-Y.LawY.H.WongH.H.LohMolecular mechanisms and regulation of opioid receptor signalingAnnu Rev Pharmacol Toxicol4012000389430
   Google Scholar
• S.BurrisJ.NorlandB.R.EdlinLegal aspects of providing naloxone to heroin users in the United StatesInt J Drug Policy1232001237248
   Google Scholar
• S.ShahabiH.AziziE.MazloomiK.H.TappehS.SeyediH.MohammadzadehA novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium bergheiImmunol Invest4372014653666
   PubMed Web of Science ®Google Scholar
• A.Z.MomeniT.JalayerM.EmamjomehA randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in IranVaccine1751999466472
   PubMed Web of Science ®Google Scholar
• J.M.MutisoJ.C.MachariaR.M.MutisyaE.TarachaSubcutaneous immunization against Leishmania major-infection in mice: efficacy of formalin-killed promastigotes combined with adjuvantsRevista do Instituto de Medicina Tropical de São Paulo.522201095100
   Web of Science ®Google Scholar
• Bari A.UlEpidemiology of cutaneous leishmaniasisJ Pakistan Assoc Dermatol162006156162
   Google Scholar
• N.H.JazaniM.KarimzadE.MazloomiEvaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccineMicrobes Infect1252010382388
   Web of Science ®Google Scholar
• A.JamaliM.MahdaviS.ShahabiNaloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB/c miceMicrob Pathog4352007217223
   Web of Science ®Google Scholar
• A.AwasthiR.K.MathurB.SahaImmune response to Leishmania infectionIndian J Med Res11962004238
   PubMed Web of Science ®Google Scholar
• M.GicheruJ.MutisoJ.MachariaH.OzwaraImmunol Leishmaniasis2013
   Google Scholar
• Dunning N. Bioscience Horizons Advance Access published February 17, 2009; 2009.
   Google Scholar
• S.C.MendonçaDifferences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discoveryParasites Vectors912016492
   PubMed Web of Science ®Google Scholar
• R.KumarC.EngwerdaVaccines to prevent leishmaniasisClin Transl Immunol332014e13
   PubMedGoogle Scholar
• J.M.MutisoJ.C.MachariaM.M.GicheruA review of adjuvants for Leishmania vaccine candidatesJ Biomed Res24120101625
   PubMedGoogle Scholar
• S.SrivastavaP.ShankarJ.MishraS.SinghPossibilities and challenges for developing a successful vaccine for leishmaniasisParasites Vectors912016277
   PubMed Web of Science ®Google Scholar
• R.T.KenneyD.L.SacksJ.P.SypekL.VilelaA.A.GamK.Evans-DavisProtective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasisJ Immunol1638199944814488
   PubMed Web of Science ®Google Scholar
• H.M.HajipirlooA.BozorgomdS.ShahabiK.H.TappehS.A.KaramatiEvaluation of alum-naltrexone adjuvant activity, on efficacy of anti-leishmania immunization with autoclaved leishmania major (MRHO/IR/75/ER) antigens in BALB/C miceIran J Parasitol932014311
   Web of Science ®Google Scholar
• P.G.FallonH.E.JolinP.SmithIL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13Immunity1712002717
   PubMed Web of Science ®Google Scholar
• C.M.SnapperC.PeschelW.E.PaulIFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharideJ Immunol1407198821212127
   PubMed Web of Science ®Google Scholar
• N.H.JazaniM.SohrabpourE.MazloomiS.ShahabiA novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccineFEMS Immunol Med Microbiol61120115462
   Google Scholar